He Jiankui (Post-Prison Disclosure-Window Probe, 2022-2026)
playerOccult & Esoteric · Nations & Geopolitics · Biotech & Transhumanism
The scientist jailed for creating the world's first gene-edited babies is already back, planning new gene therapies.
Who they are
He Jiankui, the Chinese scientist who made the first gene-edited human babies.
What they do
The engine reads him as a case where a disgraced operator's ambition outlasts his professional banishment.
How it works
In 2018 he used CRISPR to edit the CCR5 gene in embryos, resulting in three genetically modified children (Lulu, Nana, Amy) for HIV resistance; he served a 3-year prison sentence in China and was released in 2022; by 2025 he announced plans for gene-therapy trials targeting Duchenne muscular dystrophy from a lab in Hainan, with private funding and lab space still accessible despite condemnation from China's academic community.
Why it matters
It matters as an example of how a banned operator keeps going, and the engine holds two readings at once, coordinated state research and a grey-zone of loosening rules, noting regulators are quietly adapting to absorb his trajectory.
The engine's record — word for word
2018: edited CCR5 gene via CRISPR-Cas9 in human embryos → birth of three genetically modified children (Lulu, Nana, Amy) for HIV resistance. International scandal; 3-year prison sentence in China for 'illegal medical practice.' Released 2022. **Sep 2023:** appointed director of Institute of Genetic Medicine at Wuchang University of Technology — appointment LOST shortly after per negative-press response (NOT current). **2025:** announced gene-therapy clinical-trial plans targeting Duchenne muscular dystrophy (DMD), affordable-genetic-therapy framing. Lab is in HAINAN, not Beijing (Beijing-lab claim in Gemini Deep Research source itself functions as announcement-layer theater). Engine framing: Substrate-vs-Announcement disclosure-window-probe pattern — operator ambition supersedes institutional excommunication; private funding + lab space remain accessible despite Chinese academic-community condemnation. Apex (a) Coordinated-state-strategic-research + (b) Turchin SDT-grey-zone both load-bearing — regulatory adaptation (FDA Plausible Mechanism Framework 2026) absorbing substrate trajectory.
Follow the trail
Walk this on the live map →